We are live on ! Find out more
CF

C.T. Fitzpatrick Vulcan Value Partners

AUM $3.29B
1-Year Est. Return 6.08%
 

C.T. Fitzpatrick is the founder of Vulcan Value Partners, a firm that seeks high-quality businesses when they trade at discounts to estimated intrinsic value. Vulcan is known for a disciplined appraisal process and a willingness to hold cash when bargains are scarce. The firm’s equities strategies are widely followed in quality-value circles.

This Fund
S&P 500
This Quarter Est. Return
+7.43%
1 Year Est. Return
-6.08%
3 Year Est. Return
+28.5%
5 Year Est. Return
+25.59%
10 Year Est. Return
+233.17%
AUM
$11.6B
AUM Growth
+$356M
Cap. Flow
-$328M
Cap. Flow %
-2.83%
Top 10 Hldgs %
46.02%
Holding
59
New
5
Increased
21
Reduced
29
Closed
4

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$180M
2
MCO icon
Moody's
MCO
+$177M
3
NTRS icon
Northern Trust
NTRS
+$153M
4
SPGI icon
S&P Global
SPGI
+$150M
5
SABR icon
Sabre
SABR
+$98.4M

Sector Composition

Rank Sector Weight
1 Financials 28.86%
2 Healthcare 19.9%
3 Technology 19.5%
4 Consumer Discretionary 7.99%
5 Industrials 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLKN icon
51
MillerKnoll
MLKN
$1.57B
$32.2M 0.28%
1,020,537
+70,836
+7% +$2.19M
THR
52
DELISTED
Thermon Group Holdings
THR
$30.2M 0.26%
1,446,815
-88,556
-6% -$1.77M
WWD icon
53
Woodward
WWD
$20.3B
$27.6M 0.24%
407,060
+23,339
+6% +$1.61M
OUT icon
54
Outfront Media
OUT
$5.25B
$18M 0.16%
687,928
-285,925
-29% -$7.47M
PK icon
55
Park Hotels & Resorts
PK
$3.18B
$4.99M 0.04%
+194,437
New +$5.16M
BEN icon
56
Franklin Templeton, Inc.
BEN
$17.4B
-5,400,910
Closed -$214M
IWD icon
57
iShares Russell 1000 Value ETF
IWD
$84.2B
-3,203
Closed -$359K
SPY icon
58
State Street SPDR S&P 500 ETF Trust
SPY
$809B
-15,126
Closed -$3.38M
CEB
59
DELISTED
CEB Inc.
CEB
-557,940
Closed -$33.8M

Similar funds

C.T. Fitzpatrick's Q1 2017 Portfolio in Review

As of Q1 2017, C.T. Fitzpatrick held 59 positions worth $11.6B, up 3.2% from $11.2B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

C.T. Fitzpatrick's Q1 2017 filing shows 5 new, 21 increased, 29 reduced and 4 closed positions. Its largest new stake was Moody's: 1,653,477 shares worth $185M. The largest sale was Franklin Templeton, Inc., an estimated $214M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.

  • C.T. Fitzpatrick's largest Q1 2017 buy was Moody's: 1,653,477 shares worth $185M.
  • C.T. Fitzpatrick added most to CVS Health in Q1 2017, an estimated $180M increase.
  • C.T. Fitzpatrick's biggest Q1 2017 reduction was Elevance Health, cutting an estimated $210M.
  • C.T. Fitzpatrick fully exited Franklin Templeton, Inc. in Q1 2017, selling an estimated $214M.
  • C.T. Fitzpatrick's ten largest holdings make up 46% of its $11.6B portfolio in Q1 2017.
  • C.T. Fitzpatrick opened 5 new positions and closed 4 in Q1 2017.
  • C.T. Fitzpatrick's portfolio value rose 3.2% quarter-over-quarter to $11.6B.

Based on Vulcan Value Partners's 13F filing for Q1 2017, filed 15 May 2017.